InvestorsObserver
×
News Home

Will Phathom Pharmaceuticals Inc (PHAT) Stay at the Top of the Healthcare Sector?

Friday, March 22, 2024 10:49 AM | InvestorsObserver Analysts

Mentioned in this article

Will Phathom Pharmaceuticals Inc (PHAT) Stay at the Top of the Healthcare Sector?

A rating of 87 puts Phathom Pharmaceuticals Inc (PHAT) near the top of the Healthcare sector according to InvestorsObserver. Phathom Pharmaceuticals Inc's score of 87 means that it ranks higher than 87% of stocks in the sector. In addition, its overall score of 45 ranks it higher than 45% of all stocks.

Overall Score - 45
PHAT has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on PHAT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 45 would rank higher than 45 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Phathom Pharmaceuticals Inc Stock Today?

Phathom Pharmaceuticals Inc (PHAT) stock is up 15.18% while the S&P 500 has fallen -0.17% as of 10:37 AM on Friday, Mar 22. PHAT has gained $1.39 from the previous closing price of $9.16 on volume of 318,004 shares. Over the past year the S&P 500 is up 32.51% while PHAT has gained 67.99%. PHAT lost -$3.93 per share the over the last 12 months. Click Here to get the full Stock Report for Phathom Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App